ISRG
HealthcareIntuitive Surgical, Inc. · Medical - Devices · $155B
What is Intuitive Surgical, Inc.?
Intuitive Surgical is a medical technology company best known for the da Vinci Surgical System, which allows surgeons to perform complex procedures through small incisions. Headquartered in Sunnyvale, California, it serves hospitals and healthcare providers across the United States and internationally.
Intuitive Surgical designs, manufactures, and markets robotic-assisted surgical platforms and related instruments. Its flagship da Vinci system enables minimally invasive surgery across a wide range of specialties. Beyond surgery, the Ion endoluminal system extends the company's reach into diagnostic procedures, including lung biopsies. Revenue flows from system placements, recurring instrument and accessory sales, and service contracts — creating a durable, multi-stream business model.
Intuitive Surgical was incorporated in 1995 and is headquartered in Sunnyvale, California.
- da Vinci Surgical System for minimally invasive robotic surgery
- Ion endoluminal system for minimally invasive lung biopsies
- Surgical instruments, stapling, and energy accessories
- Installation, maintenance, and repair service contracts
- Digital and data analytics tools for hospital program management
Is ISRG a Good Stock to Buy?
UQS Score rates ISRG as Good overall, reflecting a balanced profile with meaningful strengths and one notable area of caution.
The Risk pillar stands out as a particular strength, suggesting the business carries relatively low financial and operational vulnerability compared to sector peers. Growth and Quality ratings are also Good, pointing to a company that has demonstrated consistent operational execution and continues to expand its addressable market through new platforms and geographies.
The Valuation pillar is rated Elevated, meaning the market already prices in a great deal of future success — leaving less room for error if growth slows or competition intensifies.
Pro members can see the exact pillar breakdown and full financial metrics behind the ISRG UQS Score. Sign up free →
Past performance does not guarantee future results. UQS Score is based on fundamental data and is not a buy/sell recommendation.
Does ISRG pay dividends?
No — Intuitive Surgical, Inc. does not currently pay a dividend.
Intuitive Surgical does not currently pay a dividend. For a capital-intensive medical technology company still expanding its platform globally, retaining earnings to fund research, product development, and market penetration is a common strategic choice. Income-focused investors should factor this in, while growth-oriented investors may view the reinvestment approach as consistent with the company's long-term expansion priorities.
When does ISRG report earnings?
Intuitive Surgical reports earnings on a quarterly cadence, consistent with standard practice for US-listed public companies.
The company's Good Growth and Quality pillar ratings suggest its recent reporting periods have reflected continued procedure volume expansion and stable operational execution. Recurring revenue from instruments and services tends to provide visibility into quarterly results.
For the most recent quarter's results and upcoming reporting dates, visit Intuitive Surgical's investor relations page directly.
ISRG Price History
+60.8% over 5Y
Monthly close, adjusted for stock splits and dividend reinvestment.
What if I invested in Intuitive Surgical, Inc.?
Based on Intuitive Surgical, Inc.'s historical closing prices, adjusted for stock splits and dividend reinvestment. Past performance does not guarantee future results. This is for informational purposes only and is not financial advice.
ISRG Long-term Outlook
Intuitive Surgical's fundamental outlook is shaped by a Good Growth profile and a Strong Risk rating — a combination that suggests the business is expanding while maintaining financial resilience. The primary uncertainty is whether the current Elevated Valuation can be sustained if procedure growth moderates or if new entrants begin to erode pricing power in robotic surgery.
Growth drivers
- Expanding global adoption of robotic-assisted surgical procedures
- New platform extensions such as the Ion system opening diagnostic markets
- Recurring instrument and service revenue growing alongside installed base
Key risks
- Elevated valuation leaves limited margin of safety if growth disappoints
- Emerging competition in surgical robotics from well-funded rivals
- Healthcare reimbursement pressures affecting hospital capital spending
ISRG vs Peers
Intuitive Surgical operates in the broader medical technology landscape alongside companies that address different aspects of surgical and diagnostic care.
EssilorLuxottica focuses on vision care products and eyewear rather than surgical robotics, representing a different segment of the medical device market.
Becton Dickinson competes across a broad range of medical supplies and diagnostics, with a more diversified product portfolio than Intuitive Surgical's robotics-focused model.
Alcon specializes in eye care surgical equipment and vision products, sharing the medical device space but targeting a distinct clinical area.
Frequently Asked Questions
What does Intuitive Surgical do?
Intuitive Surgical develops robotic-assisted surgical systems, most notably the da Vinci Surgical System, which helps surgeons perform complex procedures through small incisions. The company also offers the Ion system for minimally invasive lung biopsies, along with instruments, accessories, and service contracts that support its installed base of systems worldwide.
Does ISRG pay dividends?
Intuitive Surgical does not currently pay a dividend. The company reinvests its earnings into research, platform development, and global market expansion. Investors seeking regular income should be aware of this, while those focused on long-term growth may view the reinvestment strategy as aligned with the company's trajectory.
When does ISRG report earnings?
Intuitive Surgical follows a standard quarterly earnings reporting schedule. Specific dates are not covered by our data source. For the most accurate and up-to-date earnings calendar, check the company's investor relations page or a financial data provider directly.
Is ISRG a good stock to buy?
UQS Score rates ISRG as Good overall. The Risk pillar is rated Strong and both Growth and Quality are Good, reflecting a well-run business with expanding reach. However, the Valuation pillar is Elevated, which means the stock may already reflect a great deal of optimism. The full pillar breakdown is available to Pro members.
Is ISRG overvalued?
The UQS Valuation pillar for ISRG is rated Elevated, indicating the stock trades at a premium relative to fundamental benchmarks. This does not automatically make it a poor investment, but it does mean investors are paying for expected future growth — and any shortfall in that growth could weigh on returns.
How does ISRG compare to its competitors?
Intuitive Surgical occupies a distinctive position in medical technology through its focus on robotic-assisted surgery. Peers like Becton Dickinson operate across a much broader product range, while Alcon and EssilorLuxottica address entirely different clinical areas. ISRG's recurring revenue model from instruments and services sets it apart from more transactional device businesses.
What is ISRG's market cap bracket?
Intuitive Surgical is classified as a large-cap company. This places it among the more established and widely followed names in the healthcare and medical technology sector, typically associated with greater liquidity and institutional coverage than smaller peers.
Who founded Intuitive Surgical?
Intuitive Surgical was incorporated in 1995. Founding details, including the names of its original founders, are widely available through the company's official history and public filings. The company has grown significantly since its early days to become a leading name in surgical robotics.
Is ISRG a long-term quality stock?
As a long-term quality indicator, ISRG's UQS profile shows strengths in Risk, Growth, and Quality — pillars that tend to matter most over extended holding periods. The Elevated Valuation is a factor to monitor, as entry price can influence long-term outcomes even for fundamentally strong businesses. Pro members can view the complete analysis.
What is the main competitive advantage of Intuitive Surgical?
Intuitive Surgical benefits from deep integration into hospital workflows, a large installed base of da Vinci systems, and the recurring revenue that comes from instruments and service contracts tied to those systems. Surgeon training and institutional familiarity with the platform also create meaningful switching costs over time.
What sector does ISRG belong to?
Intuitive Surgical operates in the Healthcare sector, specifically within medical technology and surgical robotics. It serves hospitals and healthcare providers globally, and its performance is influenced by factors such as healthcare spending, surgical procedure volumes, and hospital capital budgets.
Unlock Full ISRG Analysis
Sign in to unlock the detailed analysis behind the UQS Score.
- ✓View the exact UQS pillar scores for ISRG
- ✓Access full financial metrics and quality indicators
- ✓Compare ISRG against sector peers side by side
- ✓Track changes to ISRG's UQS Score over time
- ✓Screen for stocks with similar quality and risk profiles
Pro Analysis
ISRG — Score History
| Date | UQS | Quality | Moat | Growth | Risk | Value | Change |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | 65.8 | 72.7 | 58.0 | 81.4 | 82.4 | 30.2 | +0.8 |
| May 7, 2026 | 65.0 | 69.4 | 58.0 | 81.4 | 82.4 | 30.2 | 0.0 |
| May 4, 2026 | 65.0 | 69.4 | 58.0 | 81.4 | 82.4 | 30.0 | 0.0 |
| May 3, 2026 | 65.0 | 69.4 | 58.0 | 81.4 | 82.4 | 29.8 | +0.2 |
| Apr 26, 2026 | 64.8 | 69.4 | 58.0 | 81.4 | 82.4 | 29.0 | -0.1 |
| Apr 24, 2026 | 64.9 | 69.4 | 58.0 | 81.4 | 82.4 | 29.4 | +0.2 |
| Apr 23, 2026 | 64.7 | 69.4 | 58.0 | 80.8 | 82.4 | 28.9 | +0.3 |
| Apr 19, 2026 | 64.4 | 69.4 | 58.0 | 79.9 | 82.4 | 28.1 | -0.1 |
| Apr 18, 2026 | 64.5 | 69.5 | 58.0 | 79.9 | 82.4 | 28.6 | -1.1 |
| Apr 17, 2026 | 65.6 | 69.5 | 58.0 | 79.9 | 82.4 | 35.7 | +0.1 |
ISRG — Pillar Breakdown
Quality
— 72.8/100 (25%)Intuitive Surgical, Inc. shows solid profitability with healthy returns on capital and reasonable margins.
How effectively capital is deployed to generate returns.
Profitability relative to shareholders' equity.
Ability to convert revenue into operating profit.
Bottom-line profit as a share of revenue.
Asset productivity — how much gross profit each dollar of assets generates.
Free cash flow relative to market value.
Growth
— 81.4/100 (20%)Intuitive Surgical, Inc. is growing rapidly with strong revenue and earnings expansion.
Revenue trajectory over the last twelve months.
Compound annual revenue growth rate over 3 years.
Year-over-year earnings per share growth.
Analyst consensus for future revenue growth.
Analyst consensus for future earnings growth.
Risk
— 82.4/100 (15%)Intuitive Surgical, Inc. carries minimal financial risk with conservative leverage and strong solvency.
Debt levels relative to earnings capacity.
Total debt relative to shareholder equity.
Short-term liquidity — ability to pay near-term obligations.
Earnings capacity relative to interest payments.
Valuation
— 30.6/100 (15%)Intuitive Surgical, Inc. appears expensively valued relative to its fundamentals and growth prospects.
Inverse of forward P/E — higher yield means cheaper stock.
How many years of FCF the market cap represents.
P/E relative to earnings growth — lower is more attractive.
Enterprise value multiple relative to sector median.
Moat
— 58/100 (25%)Intuitive Surgical, Inc. has meaningful competitive advantages that should protect its market position. The Moat pillar evaluates competitive advantages across five dimensions: Switching Costs, Network Effects, Cost Advantage, Intangible Assets, and Scale & Ecosystem. Sign in to customize moat ratings for ISRG.
Score Composition
Financial Data
More Stock Analysis
How is the ISRG UQS Score Calculated?
The UQS (Unified Quality Score) for Intuitive Surgical, Inc. is calculated using a proprietary 6-pillar framework with 29 financial metrics. Each pillar evaluates a different dimension on a 0–100 scale, then combines into a single weighted score. Scoring thresholds are calibrated per sector. Momentum is an optional Pro toggle — without it, you get the 5-pillar / 25-metric core shown below.
Quality (25%) measures profitability and capital efficiency — ROIC, ROE, margins, GP/Assets, and FCF Yield.
Moat (25%) assesses Intuitive Surgical, Inc.'s competitive advantages across switching costs, network effects, cost advantages, intangible assets, and ecosystem scale.
Growth (20%) tracks revenue trajectory and earnings momentum, combining historical results with analyst forward estimates.
Risk (15%) is inversely scored — lower leverage and strong balance sheet health result in higher scores.
Valuation (15%) measures whether Intuitive Surgical, Inc. is fairly priced using earnings yield, price-to-FCF, PEG ratio, and EV/EBITDA relative to sector peers.
Six investor-inspired presets are available, each with different pillar weights: Balanced, Buffett, Munger, Lynch, Cathie Wood, and Graham. The public score shown here uses the Balanced preset. Learn more in our FAQ.